Six Tools. Six Workflows. Zero Integration.
Today's molecular biology researcher runs six or more disconnected software tools in a single experiment — a primer design tool that doesn't talk to the PCR optimizer, a docking platform that can't read the structure predictor's output, and a clinical database with no connection to the genomic pipeline.
Every handoff is a manual reformatting job. Every tool charges separately, and every one of them sends your data to a cloud server you don't control. This is not a productivity problem. It is a structural failure of the biotech software industry — and it costs researchers 60%–70% of their time.
Siloed, Single-Purpose Tools
Every major biotech AI solves one problem. AlphaFold folds proteins. Schrödinger runs docking. Benchling logs lab data. The researcher manually stitches outputs together — introducing error and wasting hours at every handoff.
Your Genomic Data Is Not Safe in the Cloud
Sending patient genomic sequences, clinical trial data, or proprietary compound structures to third-party APIs is a legal and ethical exposure. HIPAA, GDPR, and institutional data governance policies are incompatible with most current biotech AI platforms.
Enterprise Pricing Excludes Most Labs
Schrödinger's platform costs tens of thousands of dollars annually. The majority of research labs worldwide — and virtually every academic lab in India — cannot access state-of-the-art computational biology tools.
No System Covers the Full Research Lifecycle
From gene sequence to validated experimental protocol, a researcher touches at minimum six systems. No platform today automates primer design, structure prediction, molecular docking, and clinical reasoning under one sovereign roof.
VigyanLLM is purpose-built to solve this — one platform, one pipeline, one sovereign infrastructure. Built in India for Indian research labs, VigyanLLM ensures your data never crosses borders while providing enterprise-grade molecular biology tools.
See Our Solution →